{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:54:05Z","timestamp":1790679245237,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"The Childrens Fund for Health","award":["13.008"],"award-info":[{"award-number":["13.008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13023-016-0521-0","type":"journal-article","created":{"date-parts":[[2016,10,10]],"date-time":"2016-10-10T08:36:40Z","timestamp":1476088600000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["Parents\u2019 experiences of living with, and caring for children, adolescents and young adults with Mucopolysaccharidosis (MPS)"],"prefix":"10.1186","volume":"11","author":[{"given":"S.","family":"Somanadhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. J.","family":"Larkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,10]]},"reference":[{"key":"521_CR1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ymgme.2013.11.015","volume":"111","author":"J Muenzer","year":"2014","unstructured":"Muenzer J. Early initiation of enzyme replacement therapy for the mucopolysaccharidoses, Minireview. Mol Genet Metab. 2014;111:63\u201372.","journal-title":"Mol Genet Metab"},{"key":"521_CR2","volume-title":"Lysosomal Storage Disorders, A Practical Guide","author":"R Giugliani","year":"2012","unstructured":"Giugliani R. The Mucopolysaccharidoses. In: Mehta A, Winchester B, editors. Lysosomal Storage Disorders, A Practical Guide. UK: Wiley-Blackwell; 2012."},{"issue":"5","key":"521_CR3","doi-asserted-by":"crossref","first-page":"v4","DOI":"10.1093\/rheumatology\/ker394","volume":"50","author":"J Muenzer","year":"2011","unstructured":"Muenzer J. Overview of the Mucopolysaccharidoses. Rheumatology. 2011;50(5):v4\u201312.","journal-title":"Rheumatology"},{"key":"521_CR4","volume-title":"Mucopolysaccharidoses: A Guide for Physicians and Parents","author":"GS Kircher","year":"2007","unstructured":"Kircher GS, Bajbouj M, Miebach E. Mucopolysaccharidoses: A Guide for Physicians and Parents. Germany: UNI-MED Verlag AG; 2007."},{"key":"521_CR5","first-page":"11","volume-title":"A Core Care Pathway for Children with Life-limiting and Life-threatening Conditions","author":"Together for Short Lives","year":"2013","unstructured":"Together for Short Lives. A Core Care Pathway for Children with Life-limiting and Life-threatening Conditions. Bristol: Together for Short Lives; 2013. p. 11. Available at: http:\/\/www.togetherforshortlives.org.uk\/assets\/0000\/4121\/TfSL_A_Core_Care_Pathway__ONLINE_.pdf ."},{"key":"521_CR6","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/sj.ejhg.5201623","volume":"14","author":"E Piotrowska","year":"2006","unstructured":"Piotrowska E, Jak\u00f3bkiewicz-Banecka J, Bara\u0144ska S, Tylki-Szyma\u0144ska A, Czartoryska B, Wegrzyn A, Wegrzyn GE. Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses. Eur J Hum Genet. 2006;14:846\u201352.","journal-title":"Eur J Hum Genet"},{"key":"521_CR7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10545-010-9215-2","volume":"34","author":"G Schulze-Frenking","year":"2011","unstructured":"Schulze-Frenking G, Jones SA, Roberts J, Beck M, Wraith JE. Effects of enzyme replacement therapy on growth in patients with mucopolysaccharidosis type II. J Inherit Metab Dis. 2011;34:203\u20138.","journal-title":"J Inherit Metab Dis"},{"key":"521_CR8","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1399-0004.2009.01324.x","volume":"77","author":"JJ McGill","year":"2010","unstructured":"McGill JJ, Inwood AC, Coman DJ, Lipke ML, de Lore D, Swiedler SJ, Hopwood JJ. Enzyme replacement therapy for Mucopolysaccharidoses VI from 8\u00a0weeks of age\u2013a sibling control study. Clin Genet. 2010;77:492\u20138.","journal-title":"Clin Genet"},{"key":"521_CR9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1172-9-32","volume":"9","author":"C Hendriksz","year":"2014","unstructured":"Hendriksz C, Lavery C, Coker M. Burden of disease in patients with Morquio A syndrome results from an international patient-reported outcomes survey. Orphanet J Rare Dis. 2014;9:3.","journal-title":"Orphanet J Rare Dis"},{"key":"521_CR10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ymgme.2013.01.021","volume":"109","author":"P Harmatz","year":"2013","unstructured":"Harmatz P, Mengel KE, Giugliani R, Valayannopoulos V, Lin SP, Parini R, Guffon N, Burton BK, Hendriksz CJ, Mitchell J, Martins A, Jones S, Guelbert N, Vellodi A, Hollak C, Slasor P, Decker C. The Morquio A Clinical Assessment Program: baseline results illustrating progressive, multisystemic clinical impairments in Morquio A subjects. Mol Genet Metab. 2013;109:54\u201361.","journal-title":"Mol Genet Metab"},{"key":"521_CR11","doi-asserted-by":"crossref","first-page":"e3746","DOI":"10.1542\/peds.2006-2156","volume":"120","author":"JE Wraith","year":"2007","unstructured":"Wraith JE, Beck M, Lane R, van der Ploeg A, Shapiro E, Xue Y, Kakkis ED, Guffon N. Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (peroxidase). Pediatrics. 2007;120:e3746.","journal-title":"Pediatrics"},{"key":"521_CR12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10545-012-9558-y","volume":"36","author":"S Grant","year":"2013","unstructured":"Grant S, Cross E, Wraith EJ, Jones S, Mahon L, Lomax M, Brigger B, Hare D. Parental social support, coping strategies, resilience factors, stress, anxiety and depression levels in parents of children with MPS III (Sanfilippo syndrome) or children with intellectual disabilities (ID). J Inherit Metab Dis. 2013;36:281\u201391.","journal-title":"J Inherit Metab Dis"},{"issue":"9","key":"521_CR13","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1651-2227.2012.02680.x","volume":"101","author":"C Malcolm","year":"2012","unstructured":"Malcolm C, Hain R, Gibson F, Adams S, Anderson G, Forbat L. Challenging symptoms in children with rare life-limiting conditions (LLCs): findings from a prospective diary and interview study with families. Acta Paediatr. 2012;101(9):985\u201392.","journal-title":"Acta Paediatr"},{"key":"521_CR14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/0269216310391346","volume":"25","author":"C Malcolm","year":"2011","unstructured":"Malcolm C, Forbat L, Anderson G, Gibson F, Hain R. Challenging symptom profiles of life-limiting conditions in children: a survey of care professionals and families. Palliat Med. 2011;25:357\u201364.","journal-title":"Palliat Med"},{"key":"521_CR15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.braindev.2008.12.010","volume":"32","author":"SK Ucar","year":"2010","unstructured":"Ucar SK, Ozbaran B, Demiral N, Yuncu Z, Erermis S, Coker M. Clinical overview of children with Mucopolysaccharidosis type III A and effect of Risperidone treatment on children and their mothers psychological status. Brain Dev. 2010;32:156\u201361.","journal-title":"Brain Dev"},{"issue":"1","key":"521_CR16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/adc.73.1.77","volume":"73","author":"MC Bax","year":"1995","unstructured":"Bax MC, Colville GA. Behaviour in mucopolysaccharide disorders. Arch Dis Child. 1995;73(1):77\u201381.","journal-title":"Arch Dis Child"},{"key":"521_CR17","first-page":"185","volume":"27","author":"FD Nidiffer","year":"1983","unstructured":"Nidiffer FD, Kelly TE. Developmental and degenerative patterns associated with cognitive, behavioural and motor difficulties in the Sanfilippo syndrome: an epidemiological study. J Ment Defic Res. 1983;27:185\u2013203.","journal-title":"J Ment Defic Res"},{"key":"521_CR18","first-page":"96","volume":"11","author":"A Soni-Jaiswal","year":"2016","unstructured":"Soni-Jaiswal A, Mercer J, Jones AS, Bruce A, Callergy P. Mucopolysaccharidosis I; Parental beliefs about the impact of disease on the quality of life of their children. Orphanet J Rare Dis. 2016;11:96.","journal-title":"Parental beliefs about the impact of disease on the quality of life of their children. Orphanet J Rare Dis."},{"key":"521_CR19","volume-title":"The Lived Experince of Parents with Children Diagnosed with Mucopolysaccharidosis waiting for Enzyme Replacement Therapy","author":"M Maione","year":"2008","unstructured":"Maione M. The Lived Experince of Parents with Children Diagnosed with Mucopolysaccharidosis waiting for Enzyme Replacement Therapy. 2008. Available at http:\/\/www.mpssociety.ca\/research\/Maione%20thesis.2008.pdf ."},{"key":"521_CR20","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/0277-9536(95)00112-K","volume":"41","author":"World Health Organization Quality of Life assessment (WHOQOL)","year":"1995","unstructured":"World Health Organization Quality of Life assessment (WHOQOL). Position paper from the World Health Organization. Soc Sci Med. 1995;41:1403\u20139.","journal-title":"Soc Sci Med"},{"key":"521_CR21","volume-title":"An investigation into the social support needs of families who experience rare disorders on the Island of Ireland","author":"B McGarvey","year":"2008","unstructured":"McGarvey B, Hart C. An investigation into the social support needs of families who experience rare disorders on the Island of Ireland. Dublin: RehabCare; 2008."},{"key":"521_CR22","unstructured":"The UK Strategy for Rare Diseases. 2013 Available at: https:\/\/www.gov.uk\/government\/publications\/rare-diseases-strategy"},{"key":"521_CR23","volume-title":"National Rare Disease Plan for Ireland 2014 \u2013 2018","author":"Department of Health (DOH)","year":"2014","unstructured":"Department of Health (DOH). National Rare Disease Plan for Ireland 2014 \u2013 2018. Dublin 2: Hawkins House; 2014."},{"key":"521_CR24","unstructured":"National Action League for People with Rare Diseases (NAMSE) National Plan of Action for People with Rare Diseases. 2013, Action files, Recommendations, Proposed Actions, Available at: http:\/\/www.namse.de\/images\/stories\/Dokumente\/Aktionsplan\/national%20plan%20of%20action.pdf ."},{"key":"521_CR25","volume-title":"Rare Diseases Europe, The Voice of Rare DiseasePatients in Europe, About Rare Diseases","author":"EURORDIS","year":"2014","unstructured":"EURORDIS. Rare Diseases Europe, The Voice of Rare DiseasePatients in Europe, About Rare Diseases. 2014. Available at: http:\/\/www.eurordis.org\/about-rare-diseases ."},{"key":"521_CR26","first-page":"33","volume-title":"Qualitative Methods for Health Research","author":"J Green","year":"2009","unstructured":"Green J, Thorogood N. Qualitative Methods for Health Research. 2009. p. 33."},{"key":"521_CR27","volume-title":"Being and Time (Trans. By J. Mac And E. Robinson)","author":"M Heidegger","year":"1962","unstructured":"Heidegger M. Being and Time (Trans. By J. Mac And E. Robinson). New York: Harper and Row; 1962."},{"key":"521_CR28","volume-title":"Philosophical Hermeneutics (David E. Linge, trans)","author":"HG Gadamer","year":"1976","unstructured":"Gadamer HG. Philosophical Hermeneutics (David E. Linge, trans). 2 revisedth ed. New York: Continuum Publishing Co; 1976.","edition":"2 revised"},{"key":"521_CR29","volume-title":"Truth and Method (Weinsheimer, J., and Marshall, D.G. Berkeley)","author":"HG Gadamer","year":"1996","unstructured":"Gadamer HG. Truth and Method (Weinsheimer, J., and Marshall, D.G. Berkeley). California: University of California Press; 1996."},{"key":"521_CR30","volume-title":"Researching Lived Experience: Human Science for an action sensitive pedagogy","author":"M Manen Van","year":"1997","unstructured":"Van Manen M. Researching Lived Experience: Human Science for an action sensitive pedagogy. 1st ed. Canada: The Althouse Press; 1997.","edition":"1"},{"key":"521_CR31","volume-title":"Researching Lived Experience: Human Science for an action sensitive pedagogy","author":"M Manen Van","year":"2007","unstructured":"Van Manen M. Researching Lived Experience: Human Science for an action sensitive pedagogy. 2nd ed. Canada: The Althouse Press; 2007.","edition":"2"},{"key":"521_CR32","volume-title":"Phenomenology of Practice","author":"M Manen Van","year":"2014","unstructured":"Van Manen M. Phenomenology of Practice. USA: Left Coast Press, Inc.; 2014."},{"issue":"2","key":"521_CR33","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1365-2648.2010.05459.x","volume":"67","author":"A Haahr","year":"2011","unstructured":"Haahr A, Kirkevold M, Hall EO, Ostergaard K. Living with advanced Parkinson's disease: A constant struggle with unpredictability. J Adv Nurs. 2011;67(2):408\u201317.","journal-title":"J Adv Nurs"},{"key":"521_CR34","volume-title":"Nursing Research: An Introduction","author":"P Moule","year":"2009","unstructured":"Moule P, Goodman M. Nursing Research: An Introduction. 1st ed. London: Sage Publications; 2009.","edition":"1"},{"issue":"2","key":"521_CR35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.atg.2014.04.003","volume":"3","author":"D Mascalzoni","year":"2013","unstructured":"Mascalzoni D, Paradisob A, Hansson M. Rare disease research: Breaking the privacy barrier. Appl Transl Genomics. 2013;3(2):23\u20139.","journal-title":"Appl Transl Genomics"},{"key":"521_CR36","volume-title":"The rites of passage","author":"A Gennep Van","year":"1960","unstructured":"Van Gennep A. The rites of passage. Chicago: University of Chicago Press; 1960."},{"issue":"1","key":"521_CR37","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1046\/j.1440-1800.2003.00157.x","volume":"10","author":"J Draper","year":"2003","unstructured":"Draper J. Men\u2019s passage to fatherhood: an analysis of the contemporary relevance of transition theory. Nurs Inq. 2003;10(1):66\u201377.","journal-title":"Nurs Inq"},{"key":"521_CR38","volume-title":"From Ritual to Theatre, The Human Seriousness of play","author":"V Turner","year":"1982","unstructured":"Turner V. From Ritual to Theatre, The Human Seriousness of play. New York: PAJ Publications; 1982."},{"key":"521_CR39","volume-title":"The big study for life-limited children and their families: final research report","author":"A Hunt","year":"2013","unstructured":"Hunt A, Coad J, West E, Hex N, Staniszewska S, Hacking S, Farman M, Brown E, Owens C, Ashley N, Kaur J, May K, Chandler V, Barron D, Wik A, Magee H, Lowson K, Wright D, Gunn K. In: Kelly K, Woodhead S, editors. The big study for life-limited children and their families: final research report. Bristol: Together for Short Lives; 2013."},{"issue":"2","key":"521_CR40","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/1049732312467232","volume":"23","author":"BL Rallison","year":"2012","unstructured":"Rallison BL, Raffin-Boucha LS. Living in the In-Between: Families Caring for a Child With a Progressive Neurodegenerative Illness. Qual Health Res. 2012;23(2):194\u2013206.","journal-title":"Qual Health Res"},{"issue":"12","key":"521_CR41","doi-asserted-by":"crossref","first-page":"576","DOI":"10.12968\/ijpn.2006.12.12.22544","volume":"12","author":"R Steele","year":"2006","unstructured":"Steele R, Davies B. Impact on parents when a child has a progressive, life-threatening illness. Int J Palliat Nurs. 2006;12(12):576\u201385.","journal-title":"Int J Palliat Nurs"},{"issue":"5","key":"521_CR42","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.eurpsy.2014.12.008","volume":"30","author":"F Muscara","year":"2015","unstructured":"Muscara F, McCarthy MC, Woolf C, Hearts SJ, Burke K, Anderson VA. Early psychological reactions in parents of children with a life-threatening illness within a pediatric hospital setting. Eur Psychiatry. 2015;30(5):555\u201361.","journal-title":"Eur Psychiatry"},{"key":"521_CR43","first-page":"6","volume":"29","author":"MG Pam","year":"2002","unstructured":"Pam MG. Beginning Treatment for Childhood Acute Lymphoblastic Leukemia: Insights From the Parents\u2019 Perspective. Oncol Nurs Forum. 2002;29:6.","journal-title":"Oncol Nurs Forum"},{"key":"521_CR44","unstructured":"Courtney E. Exploring the Palliative Care Needs and Delivery of Services to Young Children with Life-Limiting Neurodevelopmental Disabilities and their Families: A Mixed Methods Study. 2011, Unpublished Ph.D. Thesis, Dublin City University."},{"key":"521_CR45","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.pedn.2011.07.003","volume":"27","author":"H Nicholl","year":"2012","unstructured":"Nicholl H, Begley C. Explicating caregiving by mothers if children with complex needs in Ireland: A phenomenological study. J Pediatr Nurs. 2012;27:642\u201351.","journal-title":"J Pediatr Nurs"},{"key":"521_CR46","unstructured":"Ouellet CM. \u201cMothers\u2019 Experiences of the Care Provided to their Child with a Life-Limiting Illness.\" 2009, Theses and Dissertations (Comprehensive): 945."},{"issue":"4","key":"521_CR47","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1177\/1367493514538327","volume":"19","author":"C Ward","year":"2014","unstructured":"Ward C, Glass N, Ford R. Care in the home for seriously ill children with complex needs: A narrative literature review. J Child Health Care. 2014;19(4):524\u201331.","journal-title":"J Child Health Care"},{"key":"521_CR48","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1472-6963-11-156","volume":"11","author":"K Dybwik","year":"2011","unstructured":"Dybwik K, Tollali T, Nielson E. \u201cFighting the system\u2019 families caring for ventilator-dependent children and adults with complex health care needs at home. BMC Health Serv Res. 2011;11:156.","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"521_CR49","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1542\/peds.2012-0606","volume":"129","author":"ER Elias","year":"2012","unstructured":"Elias ER, Murphy NA. Home care of children and youth with complex health care needs and technology dependencies. Pediatrics. 2012;129(5):996\u20131005.","journal-title":"Pediatrics"},{"issue":"3","key":"521_CR50","doi-asserted-by":"crossref","first-page":"16","DOI":"10.7748\/ncyp2014.04.26.3.16.e349","volume":"26","author":"C Lane","year":"2014","unstructured":"Lane C, Mason J. Meeting the needs of siblings of children with life-limiting illness. Nurs Child Young People. 2014;26(3):16\u201320.","journal-title":"Nurs Child Young People"},{"issue":"5","key":"521_CR51","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1080\/07481187.2012.753555","volume":"38","author":"J Coad","year":"2014","unstructured":"Coad J, Patel R, Murray S. Disclosing Terminal Diagnosis to Children and Their Families: Palliative Professionals\u2019 Communication Barriers. Death Stud. 2014;38(5):302\u20137.","journal-title":"Death Stud"},{"issue":"2","key":"521_CR52","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/1049909107312592","volume":"25","author":"JM Sheetz","year":"2008","unstructured":"Sheetz JM, Bowman MAS. Pediatric palliative care: An assessment of physicians\u2019 confidence in skills, desire for training and willingness to refer to the end of life care. Am J Hosp Palliat Med. 2008;25(2):100\u20135.","journal-title":"Am J Hosp Palliat Med"},{"issue":"3","key":"521_CR53","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-2648.2006.03899.x","volume":"55","author":"D Kralik","year":"2006","unstructured":"Kralik D, Visentin K, Van Loon A. Transition: a literature review. J Adv Nurs. 2006;55(3):320\u20139.","journal-title":"J Adv Nurs"},{"key":"521_CR54","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1750-1172-6-72","volume":"6","author":"M Scarp","year":"2013","unstructured":"Scarp M, Alm\u00e1ssy Z, Beck M, et al. Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease. Orphanet J Rare Dis. 2013;6:72.","journal-title":"Orphanet J Rare Dis"},{"issue":"79","key":"521_CR55","first-page":"1","volume":"18","author":"AJ Nelson","year":"2013","unstructured":"Nelson AJ, Onwuegbuzie JA, Wines AL, Frels R. The Therapeutic Interview Process in Qualitative Research Studies. Qual Rep. 2013;18(79):1\u201317.","journal-title":"Qual Rep"},{"issue":"5","key":"521_CR56","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2648.2006.03950.x","volume":"55","author":"L Lowes","year":"2006","unstructured":"Lowes L, Lyne P. Participants\u2019 experiences of being interviewed about an emotive topic. J Adv Nurs. 2006;55(5):587\u201395.","journal-title":"J Adv Nurs"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-016-0521-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T20:45:10Z","timestamp":1498337110000},"score":1,"resource":{"primary":{"URL":"http:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-016-0521-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,10]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["521"],"URL":"https:\/\/doi.org\/10.1186\/s13023-016-0521-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,10]]},"article-number":"138"}}